A Phase 1b Open-Label, Dose Escalation and Expansion Study Evaluating the Safety and Efficacy of Entospletinib (GS-9973) with Chemotherapy in Adult Subjects with Acute Relapsed or Refractory Acute Lymphoid Leukemia (ALL) - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 1b Open-Label, Dose Escalation and Expansion Study Evaluating the Safety and Efficacy of Entospletinib (GS-9973) with Chemotherapy in Adult Subjects with Acute Relapsed or Refractory Acute Lymphoid Leukemia (ALL)

Type of Cancer
Leukemia
Locations
Hackensack
Sponsor
Gilead
Protocol Number
GS-US-339-1560
Cancer Diagnosis
To Learn More Call
201-510-0910